BNB PLUS CORP (BNBX)
NASDAQFinancialsBiotechnologySnapshot 2026-09-04
$0.14-12.50%
Close 2026-08-10 · 1-day change
NASDAQFinancialsBiotechnologySnapshot 2026-09-04
Research Workspace
Put BNBX beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Primary pillar broken — Maintain Nasdaq listing by meeting $1.00 bid price requirement: 0.14 USD vs 1.00 USD.
View ThesisRevenue is growing steadily — about 4% over the past year.
View GrowthManagement screens weak on capital allocation, margins, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 4% on a typical day and fell roughly 99% in its worst 12-month stretch.
View RiskBNBX's growth depends on maintaining its Nasdaq listing by meeting the $1.00 bid price requirement. Recent financial performance sits well below its industry cohort, which raises concerns. Revenue growth is weak, and the last quarter's performance was below expectations. BNBX trades at 0.5× P/S versus a peer median of 3.2×. The price reflects less growth than we forecast, indicating modest expectations. The primary risk is the need to meet the $1.00 bid price requirement, as it currently trades at 0.14 USD. Peer multiples imply a price about 2% above where it trades. This read is provisional.
Trailing returns as of 2026-08-10. BNBX is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Continue this research
Compare BNBX with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| BNBX Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Asset Management & Custody Banks — fair value, gap to price, and forward P/E.
Compare the value case
Put BNBX next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Address Nasdaq listing compliance
Delisting threatens compliance with Nasdaq listing requirements.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-08-10. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Threatens: Address Nasdaq listing compliance
Delisting threatens compliance with Nasdaq listing requirements.
